Viruses (Oct 2024)

The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States

  • Claire P. Smith,
  • Rachel M. Hartman,
  • Alexa M. Kugler,
  • Verlena Little,
  • Owen R. Baker,
  • Tarayn A. Fairlie,
  • Reinaldo E. Fernandez,
  • Melissa B. Hagen,
  • Elvira Honie,
  • Oliver Laeyendecker,
  • Claire M. Midgley,
  • Dennie Parker,
  • Marqia Sandoval,
  • Saki Takahashi,
  • Laura L. Hammitt,
  • Catherine G. Sutcliffe

DOI
https://doi.org/10.3390/v16101573
Journal volume & issue
Vol. 16, no. 10
p. 1573

Abstract

Read online

SARS-CoV-2 antibody kinetics based on immunologic history is not fully understood. We analyzed anti-spike and anti-nucleocapsid antibody responses following acute infection in a cohort of Indigenous persons. The models of peak concentrations and decay rates estimated that one year after infection, participants would serorevert for anti-nucleocapsid antibodies and remain seropositive for anti-spike antibodies. The peak anti-spike concentrations were higher for individuals vaccinated prior to infection, but the decay rates were similar across immunologic status groups. Children had significantly lower peak anti-spike concentrations than adults. This study affirms the importance of continued vaccination to maintain high levels of immunity in the face of waning immunity.

Keywords